Clinical Trial Update: TmPSMA-02 in mCRPC [Phase 1]

View source ↗

Summary

This update indicates a Phase 1 clinical trial of TmPSMA-02 for metastatic castration-resistant prostate cancer is currently recruiting at the University of Pen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• TmPSMA-02

Snippet

Sponsor: University of Pennsylvania | Conditions: Metastatic Castrate-Resistant Prostate Cancer (mCRPC) | Phase 1 | Status: RECRUITING